Weekend Reads Covid-19: Germany authorizes the experimental treatment used on Donald Trump

02:50  25 january  2021
02:50  25 january  2021 Source:   rfi.fr

Donald Trump Faces Possible Expulsion From SAG-AFTRA As Union’s Board Sets Special Session

  Donald Trump Faces Possible Expulsion From SAG-AFTRA As Union’s Board Sets Special Session EXCLUSIVE: Donald Trump is facing possible expulsion from SAG-AFTRA. Deadline has learned that the union’s national board of directors will meet Tuesday morning in a special session regarding disciplinary action against him, which could lead to his expulsion. The former star of The Apprentice – and soon-to-be former president – has been a member of the union and its forerunners, SAG and AFTRA, since 1989. The two unions merged in 2012.

Germany will become the first European Union country to start using the same experimental antibodies treatment credited with helping Donald Trump recover from Covid - 19 , health minister Jens Spahn said Sunday. "The government has bought 200,000 doses for 400 million euros (6 million)

Trump received an experimental treatment from Regeneron Pharmaceutical Inc. in October after he was diagnosed with Covid - 19 . The then-president was so impressed that he said he wanted to make it available for free to Americans, which ultimately didn’t occur. At least some of the doses ordered by

Le ministre de la Santé Jens Spahn à Berlin le 21 janvier 2021. © AP - Michael Kappeler Minister of Health Jens Spahn in Berlin on January 21, 2021.

Germany will become the first country of the European Union to use the experimental treatment based on synthetic antibodies administered to Donald Trump against Covid-19, Minister of Health Jens Spahn announced on Sunday, January 24.

"The government bought 200,000 doses for 400 million euros" of the experimental treatment against Covid-19 administered to Donald Trump, Jens Spahn told the newspaper Bild am Sonntag, which represents 2,000 euros per dose.

Patients will receive this therapy free of charge, said a spokesperson for the Ministry of Health. Two variations of this treatment based on “monoclonal” antibodies will be used in university hospitals next week. Jens Spahn stressed that Germany was “the first country in the EU” to use this type of therapy in the fight against the pandemic.

Trump expected to issue flurry of pardons on last full day

  Trump expected to issue flurry of pardons on last full day WASHINGTON — President Donald Trump was expected to spend his last full day in office issuing a flurry of pardons and bidding farewell to the American public from a near-deserted White House and surrounded by an extraordinary security presence outside. In one of his final acts as president, Trump was expected to grant clemency to as many as 100 people, according to two people briefed on the plans. The list of pardons and commutations is expected to include names unfamiliar to the American public — regular people who have spent years languishing in prison — as well as politically-connected friends and allies like those he’s pardoned in the past.

President Donald Trump has maintained a steady schedule of campaign rallies, which A separate trial is assessing the impact of the treatment on hospitalized COVID - 19 patients, but Regeneron has yet What’s the evidence for using remdesivir in COVID - 19 patients? Remdesivir is an antiviral drug

An experimental drug used by Donald Trump when he had COVID - 19 has received emergency approval by US health authorities. The FDA used its emergency powers to authorise the drug as the total number of coronavirus-related deaths in the US passed 256,000 amid a lack of treatments for

The two versions of this treatment were approved in November in the United States but do not yet have the green light from the European regulatory authorities. According to the spokesperson for the ministry, the German medicines regulatory authority, the Federal Institute Paul-Ehrlich, considered that the use of this therapy was "in principle" allowed on a case-by-case basis if doctors deemed it appropriate. to prevent “serious illness or hospitalizations among certain risk groups”.

Orders from two American companies

Germany has obtained supplies from two American companies, Regeneron for its Casirivimab / Imdevimab and Eli Lilly for its Bamlanivimab, the spokesperson said. Both work in a similar way, but the Regeneron version combines two synthetic antibodies and Eli Lilly's version uses only one. These antibodies mimic the functioning of the immune system after contamination by the coronavirus by going to block the tip of the virus which allows it to attach to and penetrate human cells.

Donald Trump had received Regeneron treatment in early October when he was briefly hospitalized, even before he was authorized at the end of November by the United States Medicines Agency (FDA). Eli Lilly's similar treatment had been authorized as of November 9. The ex-president touted Regeneron's treatment, saying he had "cured" him.

(With AFP)

What you need to know about COVID-19 in Ottawa on Friday, Jan. 29 .
CBC Ottawa's latest roundup of key updates during the coronavirus pandemic.In-person school is back for boards in eastern Ontario on Monday, but parents, teachers and students will notice a few changes since December.

usr: 0
This is interesting!